I

Illumina

Develops sequencing platforms and consumables

Senior or Staff Scientist - Perturb-seq

Translational Research & Bench BiologyUpdated on Nov 13
Full-timeFoster City, CA, USA

About the Job

Requirements

  • A Ph.D. in cell biology, molecular biology, bioengineering, or a similar degree, with at least 4 years of experience.
  • Extensive expertise in experimental and computational biology techniques, particularly developing and analyzing high-throughput sequencing assays, single-cell sequencing, CRISPR, cell culture and induced pluripotent stem cell models, target identification, and target validation.
  • A strong record of technical proficiency, innovation, and scientific rigor demonstrated through publication in high-quality scientific journals.

Responsibilities

  • Build the team and laboratory infrastructure for running high-throughput sequencing experiments for target identification and validation.
  • Design, develop, and validate quantitative cellular assays to credential novel targets.
  • Work with academic and clinical collaborators to integrate innovative biology with data from large-scale human genetics and high-throughput sequencing assays to develop new target hypotheses.
  • Present results at scientific meetings and publish in peer-reviewed scientific journals.
  • Design, plan, and execute laboratory experiments in support of early discovery efforts.
  • Pursue novel approaches to study a broad range of disease indications using high-throughput functional genomics strategies, focusing on identifying and validating therapeutic targets and next-generation biomarkers.
  • Provide direct technical mentorship and mentorship for laboratory-based staff.

About the Company

Illumina

Develops sequencing platforms and consumables

Illumina develops and sells integrated sequencing systems and the consumables needed to analyze genetic variation and biological function. Its instruments use sequencing-by-synthesis on flow-cell-based platforms, with specialized reagents and library preparation kits that are consumed per run. The company differentiates itself through a broad end-to-end ecosystem, a large installed base that drives repeat purchases, and strategic acquisitions that expand capabilities into multiomics and clinical applications. Its goal is to advance genomic analysis for research and clinical diagnostics to enable personalized medicine and early cancer detection.

Company size
5,001-10,000
Company stage
IPO
Headquarters
San Diego, CA
Founded
1998

Recently Posted Jobs

Explore more opportunities at Illumina

See more jobs